Yes, incision and drainage (I&D) is necessary for peritonsillar abscess even when the patient is already on ceftriaxone.
The fundamental principle is that antibiotics alone cannot adequately treat an established abscess—drainage of the purulent collection is essential for resolution. This applies regardless of whether antibiotics have already been initiated.
Why Drainage is Essential
The core issue is that antibiotics have poor penetration into abscess cavities. The purulent material creates a hypoxic, acidic environment with bacterial concentrations that exceed what systemic antibiotics can effectively treat. While ceftriaxone provides appropriate antimicrobial coverage for the typical pathogens in peritonsillar abscess (predominantly Streptococcus pyogenes and oral anaerobes), it cannot replace the need for source control through drainage 1, 2.
Evidence Supporting Drainage
Multiple studies demonstrate that drainage procedures (either needle aspiration or incision and drainage) are the cornerstone of peritonsillar abscess management:
- First-attempt success rates are high with drainage procedures: 87-90% with needle aspiration and 90-100% with incision and drainage 1, 2
- Pain relief is dramatically superior with drainage compared to antibiotics alone. One study showed 100% improvement in mouth opening 15 minutes after I&D versus only 5% improvement with IV antibiotics alone, with 92% of I&D patients able to swallow water within 2 hours versus 0% in the antibiotic-only group 3
- A recent 2026 study confirmed that I&D achieved higher first-attempt success (89.8% vs 75.9%) compared to needle aspiration 4
Practical Approach
Drainage method selection:
- Needle aspiration can be attempted first in cooperative patients and is less invasive, with success rates of 75-88% 1, 2, 4
- Incision and drainage should be performed if:
- Needle aspiration fails or yields insufficient drainage
- The abscess is large or multiloculated
- The patient has severe trismus limiting access
- This is a recurrent abscess
Antibiotic considerations: While ceftriaxone provides reasonable coverage, note that it lacks optimal anaerobic coverage. The FDA label for ceftriaxone does not specifically list peritonsillar abscess as an indication 5. Most organisms cultured from peritonsillar abscesses are streptococci (62%), and 97% respond to penicillin 1. Consider adding metronidazole or switching to amoxicillin-clavulanate for better anaerobic coverage, which is the most commonly prescribed antibiotic for this condition (61% of practitioners) 6.
Common Pitfalls to Avoid
- Do not rely on antibiotics alone for an established abscess—this leads to treatment failure, prolonged pain, and potential complications including airway compromise
- Do not delay drainage waiting for antibiotics to work—the abscess cavity prevents adequate antibiotic penetration
- Do not assume the patient is "failing" ceftriaxone—the issue is not antibiotic resistance but rather the need for mechanical drainage
Outpatient Management
After successful drainage, most patients can be managed as outpatients with oral antibiotics, adequate hydration, and pain control. Only 4.1% of patients in one protocol required subsequent intervention after initial drainage 7. Hospital admission is typically only necessary for patients requiring IV hydration, those with airway concerns, or those unable to tolerate oral intake 1, 8.